XML 21 R5.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Stockholders' Deficit - USD ($)
Preferred Stock Series X
Preferred Stock Series Y
Preferred Stock Series B
Preferred Stock Series C
Common Stock
Common Stock to be Issued
Additional Paid In Capital
Discount on Preferred Stock
Accumulated Deficit
Total
Balance at Dec. 31, 2018 $ 168,707 $ 80 $ 73,770,195 $ (80,775,348) $ (6,836,366)
Balance (in Shares) at Dec. 31, 2018 168,706,472 80,000        
Issuance of common shares previously to be issued         $ 80 $ (80)        
Issuance of common shares previously to be issued (in Shares)         80,000 (80,000)        
Issuance of Series A preferred shares in exchange for warrants canceled             (296,746)     (296,746)
Sale of Series B Convertible Preferred Stock and warrants     $ 1       1,407,499     1,407,500
Sale of Series B Convertible Preferred Stock and warrants (in Shares)     1,126              
Conversion of Series A Convertible Preferred Stock to common shares $ 80,000 $ 903,824 2,153,424 3,137,248
Conversion of Series A Convertible Preferred Stock to common shares (in Shares) 80,000,000 903,823,564        
Common shares issued as origination shares         $ 1,250   140,083     141,333
Common shares issued as origination shares (in Shares)         1,250,000          
Common shares issued upon conversion of convertible notes and accrued interest         $ 111,174 $ 37,160 1,583,984     1,732,318
Common shares issued upon conversion of convertible notes and accrued interest (in Shares)         111,174,464 37,160,000        
Common shares issued upon exercise of warrants for cash         $ 1,555 $ 1,126 170,268     172,949
Common shares issued upon exercise of warrants for cash (in Shares)         1,555,160 1,126,250        
Common shares issued in settlement of a warrant provision $ 9,000 428,400 (437,400)
Common shares issued in settlement of a warrant provision (in Shares)         9,000,000        
Common shares issued upon cashless exercise of warrants         $ 3,998   (3,998)      
Common shares issued upon cashless exercise of warrants (in Shares)         3,997,661          
Preferred and common shares issued for services       $ 1 $ 2,950 $ 2,550 203,199     208,700
Preferred and common shares issued for services (in Shares)       1,000 2,950,000 2,550,000        
Options issued for services 14,000 14,000
Common shares issued to settle a true-up provision         $ 5,553   16,661     22,214
Common shares issued to settle a true-up provision (in Shares)         5,553,191          
Contingent beneficial conversion feature on Preferred Shares issuance             45,147,093   (45,147,093)  
Deemed dividend related to warrant price protection             28,933,472   (28,933,472)
Deemed dividend resulting from exchange of preferred Series A and B shares for convertible notes             (1,476,280)     (1,476,280)
Preferred Series B shares exchanged for convertible notes     $ (1)       (826,883)     (826,884)
Preferred Series B shares exchanged for convertible notes (in Shares)     (1,126)              
Net loss (34,268,912) (34,268,912)
Balance at Dec. 31, 2019       $ 1 $ 384,267 $ 944,660 151,364,371   (189,562,225) (36,868,926)
Balance (in Shares) at Dec. 31, 2019       1,000 384,266,948 944,659,814        
Issuance of common shares previously to be issued         $ 37,160 $ (37,160)        
Issuance of common shares previously to be issued (in Shares)         37,160,000 (37,160,000)        
Common shares issued upon conversion of convertible notes and accrued interest         $ 72,369   298,386     $ 370,755
Common shares issued upon conversion of convertible notes and accrued interest (in Shares)         72,368,457         57,231
Common shares contributed back to the Company and promptly retired         $ (69)   69    
Common shares contributed back to the Company and promptly retired (in Shares)         (69,000)          
Rescission of warrants exercised in prior year $ (120) (5,880) (6,000)
Rescission of warrants exercised in prior year (in Shares) (120,000)        
Deemed dividend related to warrant price protection             95,838,488   (95,838,488)  
Convertible note issued to CFO with BCF             64,143     64,143
Sale of Series X preferred shares             321,000     321,000
Sale of Series X preferred shares (in Shares) 16.05                  
BCF recognized upon issuance of Series X preferred shares             454,200 (454,200)    
Series Y preferred shares issued in exchange for convertible notes, accrued interest and warrants   $ 1         13,095,635     13,095,636
Series Y preferred shares issued in exchange for convertible notes, accrued interest and warrants (in Shares)   654.781794                
BCF recognized upon issuance of Series Y preferred shares             21,594,115 (21,594,115)    
Deemed dividend resulting from amortization of preferred stock discount               1,074,539 (1,074,539)  
Net loss   (14,710,460) (14,710,460)
Balance at Dec. 31, 2020   $ 1   $ 1 $ 493,727 $ 907,380 $ 283,024,527 $ (20,973,776) $ (301,185,712) $ (37,733,852)
Balance (in Shares) at Dec. 31, 2020 16.05 654.781794   1,000 493,726,405 907,379,814